ALT vs CVS · rev $20.0K vs P/E 16, rev $402.07B
Altimmune Inc (ALT) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
ALT currently screens at market cap $527.0M. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the ALT and CVS stock pages for the full models.
Not investment advice.